23rd Feb 2012 17:06
PDMR Share Dealings
February 23, 2012 - Shire plc , the global specialty biopharmaceutical company announces the following dealings by Persons Discharging Managerial Responsibility ("PDMRs") in American Depository Shares ("ADSs"). One ADS is equal to three Shire plc ordinary shares of 5p.
Release of Performance Share Awards ("PSA Awards")
In accordance with the rules of the Portfolio Share Plan ("PSP"), the followingADSs were released on February 20, 2012 in connection with PSA Awards grantedin 2009 under Part B of the PSP. The Company was notified today that sufficientADSs were sold on February 21, 2012 to satisfy the personal tax liabilities ofeach PDMR. No of ADSs No of ADSs Average sale released sold price Michael Cola 15,263 6,329 $104.1994 Barbara Deptula 9,158 3,949 $104.1994 Sylvie Gregoire 15,263 5,649 $104.1994
Exercise of Stock Appreciation Right Awards ("SAR Awards")
The Company was notified today that the following SAR Awards, which were granted under Part A of the PSP, were exercised on February 22, 2012.
No of Exercise No of No of ADSs Sale price price ADSs sold ADSs exercised received Michael Cola 20,000 $38.63 12,704 12,704 $105.4991 Barbara Deptula 12,000 $38.63 7,626 7,626 $106.00
This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a) of the Disclosure and Transparency Rules.
Tony GuthrieDeputy Company Secretary
For further information please contact:
Investor Eric Rojas [email protected] +1 781 482 0999 Relations Sarah Elton-Farr [email protected] +44 1256 894157
Notes to editors
SHIRE PLC
Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit hyperactivity disorder, human genetic therapies, gastrointestinal diseases and regenerative medicine as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.
For further information on Shire, please visit the Company's website: www.shire.com.
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PXPress Release
www.shire.com
XLONRelated Shares:
Shire